SAMHSA HCV Testing – Request for Applications
. The purpose of this grant is to address the high prevalence of viral hepatitis C infection among people with a history of injecting drug use who access selected opioid treatment programs (OTPs). In addition to providing rapid hepatitis C virus testing, applicants must develop a plan for providing referrals for care and treatment that include, but are not limited to primary health care, public health, mental health, and medical services for those who are HCV positive or are at high-risk of HCV infection.
Health departments are not eligible for this funding, but we encourage you to share this with OTPs in your jurisdiction.
Anticipated Total Available Funding: $1 Million
Anticipated Number of Awards: 25
Anticipated Award Amount: Up to $40,000
Length of Project Period: One Year
Application Due: April 5, 2013
Grant funds must be used for the following activities:
• Purchase of rapid HCV test kits, test controls, other required supplies that are needed to comply with regulations related to the HCV testing process;
• Implementation of quality assurance measures to appropriately conduct rapid HCV testing; and
• Appropriate staff training as it relates to implementing proper HCV rapid screening and testing techniques.
SAMHSA is limiting eligibility for this program to certified OTPs because OTPs are optimal settings in which to provide comprehensive hepatitis prevention and control services. The majority of OTP clients have a history of injecting drugs, placing them at high risk for human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) and viral hepatitis. OTPs provide hepatitis C counseling, testing, treatment, and hepatitis A and B vaccinations, retain clients for extended periods of time, and have licensed medical facilities with medical staff. Only certified OTPs may apply because only they are qualified to provide opioid treatment under 42 CFR part 8. The statutory authority for this program prohibits grants to for-profit agencies.
For questions about grant program issues contact:
Anthony Campbell, D.O.
Division of Pharmacologic Therapy
Center for Substance Abuse Treatment
Substance Abuse and Mental Health Services Administration
Rockville, Maryland 20857
Please contact Chris Taylor if you have questions about this opportunity.
Julie M. Scofield, Executive Director
National Alliance of State & Territorial AIDS Directors (NASTAD)
444 North Capitol Street NW, Suite 339
Washington, DC 20001
Phone: (202) 434.8090 FAX: (202) 434.8092
“Bridging Science, Policy, and Public Health”Tags: Grant Hepatitis C RFP Substance Abuse